Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

IG Pharma Compliance Guide Has First Amendment Flaws, Attorney Says

Executive Summary

The HHS Inspector General's pharmaceutical compliance guide may be the next battleground for First Amendment cases, Wiley, Rein & Fielding Attorney John Kamp said at an OIG compliance guide symposium in Princeton, N.J. July 23
Advertisement

Related Content

Neurontin Ruling Is Guide For DoJ Off-Label Promotion Cases – Prosecutor
Neurontin Ruling Is Guide For DoJ Off-Label Promotion Cases – Prosecutor
Medco Reports New Problems With Mail-Order Recordkeeping
“Whistleblower” Cases Reflect Evidence, Not Personality, Prosecutor Says
Drug Manufacturer Education Grants To Purchasers May Be Kickback, IG Says
Drug Manufacturer Education Grants To Purchasers May Be Kickback, IG Says
FDA First Amendment Plan: Series Of Guidances Rather Than Omnibus Rule
FDA Chief Counsel Is Attorney From WLF Case; Porter Leaves After 11 Years
Advertisement
UsernamePublicRestriction

Register

PS042199

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel